Skip to main content
. 2024 Jun 27;13(6):999–1015. doi: 10.21037/gs-24-157

Figure 3.

Figure 3

Prognostic value of SPAG6 across cancers. (A) The correlation between OS and SPAG6 expression. (B-F) Kaplan-Meier analysis of significant outcomes in OS, namely DLBC, LAML, ALL, PAAD, and TGCT. (G) The correlation between DSS and SPAG6 expression. (H) The correlation between DFI and SPAG6 expression. (I) The correlation between PFI and SPAG6 expression. HR, hazard ratio; CI, confidence interval; NaN, not a number; L, low; H, high; OS, overall survival; DLBC, lymphoid neoplasm diffuse large b-cell lymphoma; LAML, acute myeloid leukemia; ALL, acute lymphoblastic leukemia; PAAD, pancreatic adenocarcinoma; TGCT, testicular germ cell tumor; DSS, disease-specific survival; DFI, disease-free interval; PFI, progression-free interval.